Summary by Futu AI
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 22 FEBRUARY 2024, DISCLOSING THE REPURCHASE OF UNREGISTERED SHARES FROM 19 DECEMBER 2023 TO 22 FEBRUARY 2024. According to the report, the company repurchased a total of 69,771,000 shares of ordinary shares during this period, representing 6.4179 percent of the issued shares. The last repurchase took place on 22 February 2024, repurchasing 480,000 shares at a price of HKD 1.87 to HKD 1.9 per share, with a total payment of HKD 908,150. After the repurchase, the company had a deposit of 1,044,821,000 shares on February 22, 2024. The Company confirms that all repurchases have been formally authorised by the Board of Directors and comply with the listing rules of the HKEX Main Board.